Method for manufacturing iridium complex

US10125158B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10125158-B2
Application numberUS-201515503822-A
CountryUS
Kind codeB2
Filing dateAug 28, 2015
Priority dateSep 19, 2014
Publication dateNov 13, 2018
Grant dateNov 13, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for manufacturing tris(β-diketonato)iridium by reacting β-diketone with an iridium compound, in which an activation treatment including (a) an alkali treatment and (b) an acid treatment described below is applied to the iridium compound to activate the iridium compound, and to subsequently react the β-diketone, (a) an alkali treatment: a treatment of adding alkali to a solution of the iridium compound to raise pH of the solution to a more alkaline side than that before the alkali addition and to not less than 10, and (b) an acid treatment: a treatment of adding acid to the solution subjected to the alkali treatment to lower pH of the solution to a more acidic side than that before the acid addition and to make the pH difference between solutions before and after the acid addition be not less than 0.1 and not more than 10. The present invention allows manufacture of tris(β-diketonato)iridium utilizing a wide variety of β-diketones.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for manufacturing tris(β-diketonato)iridium shown by Chem 2 in which a β-diketone is coordinated to iridium, by reacting the β-diketone shown by Chem 1 with an iridium compound which is any one of iridium nitrate (III, IV), iridium chloride (III, IV), and ammonium hexachloroiridate (III, IV), wherein an activation treatment including (a) an alkali treatment and (b) an acid treatment described below is applied to the iridium compound to activate the iridium compound, and to subsequently react the β-diketone, (a) an alkali treatment: a treatment of adding alkali to a solution of the iridium compound to raise pH of the solution to a more alkaline side than that before the alkali addition and to not less than 10, and (b) an acid treatment: a treatment of adding acid to the solution subjected to the alkali treatment to lower pH of the solution to a more acidic side than that before the acid addition and to make the pH difference between solutions before and after the acid addition be not less than 0.1 and not more than 10, wherein each of Ra and Rb is a hydrocarbon group or substituents in which a hydrogen atom in a hydrocarbon group is substituted by a halogen atom, Ra and Rb may be different substituents, or identical substituents, Rc is a substituent composed of any of a hydrogen atom, a halogen atom and a hydrocarbon group; and wherein Ra, Rb, and Rc have the same meaning as in Chem 1. 2. The method for manufacturing tris(β-diketonato)iridium according to claim 1 , wherein pH after alkali addition in the alkali treatment (a) is set to not less than 12. 3. The method for manufacturing tris(β-diketonato)iridium according to claim 1 , wherein the pH difference between solutions before and after the alkali addition in the alkali treatment (a) is set to not less than 2 and not more than 13. 4. The method for manufacturing tris(β-diketonato)iridium according to claim 1 , wherein the pH difference between solutions before and after the acid addition in the acid treatment (b) is set to not less than 1 and not more than 10. 5. The method for manufacturing tris(β-diketonato)iridium according to claim 2 , wherein the pH difference between solutions before and after the alkali addition in the alkali treatment (a) is set to not less than 2 and not more than 13. 6. The method for manufacturing tris(β-diketonato)iridium according to claim 2 , wherein the pH difference between solutions before and after the acid addition in the acid treatment (b) is set to not less than 1 and not more than 10. 7. The method for manufacturing tris(β-diketonato)iridium according to claim 3 , wherein the pH difference between solutions before and after the acid addition in the acid treatment (b) is set to not less than 1 and not more than 10.

Assignees

Inventors

Classifications

  • of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title

  • characterized by the use of precursors specially adapted for ALD · CPC title

  • containing organic luminescent materials · CPC title

  • Electricity · mapped topic

  • from metallo-organic compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10125158B2 cover?
A method for manufacturing tris(β-diketonato)iridium by reacting β-diketone with an iridium compound, in which an activation treatment including (a) an alkali treatment and (b) an acid treatment described below is applied to the iridium compound to activate the iridium compound, and to subsequently react the β-diketone, (a) an alkali treatment: a treatment of adding alkali to a solution of the …
Who is the assignee on this patent?
Tanaka Precious Metal Ind
What technology area does this patent fall under?
Primary CPC classification C07F15/004. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).